| abstract |
In one aspect, the invention relates to a composition comprising factor H binding protein (fHBP) and Neisseria meningitidis non-serogroup B capsular polysaccharide. The invention further relates to the use of a composition comprising fHBP, such as, for example, N. to the use for eliciting an immune response against meningitidis serogroup B strains and non-serogroup B strains. The compositions and methods described herein relate to administration in humans, including adults, adolescents, infants, and infants. |